e-learning
resources
Vienna 2012
Sunday, 02.09.2012
Update on neutrophil and macrophage function in COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Reduced phagocytosis of pathogenic bacteria by neutrophils from COPD patients
C. Thomas, P. Barnes, L. Donnelly (London, United Kingdom)
Source:
Annual Congress 2012 - Update on neutrophil and macrophage function in COPD
Session:
Update on neutrophil and macrophage function in COPD
Session type:
Oral Presentation
Number:
387
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Thomas, P. Barnes, L. Donnelly (London, United Kingdom). Reduced phagocytosis of pathogenic bacteria by neutrophils from COPD patients. Eur Respir J 2012; 40: Suppl. 56, 387
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Reduced phagocytosis of bacterial pathogens by macrophages from COPD patients
Source: Annual Congress 2010 - Macrophages: cell biology and disease-specific characteristics
Year: 2010
Decreased neutrophil phagocytosis and killing of bacteria in COVID-19 patients
Source: Virtual Congress 2021 – Back to infection basics
Year: 2021
Defective bacterial phagocytosis is associated with dysfunctional mitochondria in COPD macrophages
Source: Eur Respir J, 54 (4) 1802244; 10.1183/13993003.02244-2018
Year: 2019
Assessment of the phagocytic capability of sputum macrophages and neutrophils in COPD patients.
Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations
Year: 2019
Bacterial load and defective monocyte-derived macrophage bacterial phagocytosis in biomass smoke-related COPD
Source: Eur Respir J, 53 (2) 1702273; 10.1183/13993003.02273-2017
Year: 2019
Phagocytic ability of granulocytes and monocytes in elderly patients with community acquired pneumonia
Source: International Congress 2018 – Pleural diseases and pneumonia: what's new ?
Year: 2018
Mitochondrial dysfunction in macrophages: a key to defective bacterial phagocytosis in COPD
Source: Eur Respir J, 54 (4) 1901641; 10.1183/13993003.01641-2019
Year: 2019
Relationship between monocyte-derived macrophage phagocytosis and airway inflammation in stable COPD
Source: Annual Congress 2013 –COPD: experimental biology
Year: 2013
Colony stimulating factors cannot correct defective phagocytosis in COPD lung tissue macrophages
Source: International Congress 2016 – Airway response to infection
Year: 2016
Increased susceptibility of M2 monocyte-derived macrophages from COPD patients to oxidative stress
Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection
Year: 2013
Monocyte-derived macrophages from non-smoker COPD subjects exhibit defective bacterial phagocytosis
Source: International Congress 2015 – Mucosal immunology: what’s new in 2015
Year: 2015
Different expression of pro- and antiinflammatory cytokines in
chlamydia pneumoniae
infected blood monocytes and alveolar macrophages from COPD patients and healthy volunteers
Source: Eur Respir J 2002; 20: Suppl. 38, 220s
Year: 2002
Evaluation of neutrophils phagocytosis and killing in pulmonary cystic fibrosis patients
Source: International Congress 2019 – Infection and inflammation in cystic fibrosis
Year: 2019
Expression of surface receptors on alveolar macrophages and monocytes from patients with COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 453s
Year: 2004
Characterisation of defective phagocytosis by chronic obstructive pulmonary disease alveolar macrophages
Source: International Congress 2016 – New findings in mucosal immunology
Year: 2016
The relationship between blood eosinophils and bacterial load in COPD patients
Source: International Congress 2016 – What's new in biomarker analysis?
Year: 2016
Redox systems of neutrophils of patients with exacerbated COPD
Source: Annual Congress 2008 - Respiratory structure and function
Year: 2008
Bacterial exacerbation of COPD: assessment of neutrophil activation in induced sputum
Source: Annual Congress 2004 - Role of infection in COPD
Year: 2004
The species-specific inflammatory response of colonising bacteria in stable COPD
Source: Annual Congress 2013 –COPD: markers and inflammation
Year: 2013
Candidacidal activity of polymorphonuclear granulocytes (PMNs) and
Candida
hydrolytic enzymes in COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 338s
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept